From JEMS (AutoPulse)
More than 500 ZOLL AutoPulse units were deployed and more than 5,000 medics were trained on the use of the device. “On behalf of all the CIRC investigators, we are excited about the conclusion of enrollment and look forward to presenting complete results later this fall. This is the first large-scale, randomized resuscitation trial to come to a successful conclusion with a statistically significant result,” said Dr. Wik.
The trial’s Data Safety Monitoring Board (DSMB) closed enrollment when an analysis of the data showed the load-distributing band (AutoPulse® Non-invasive Cardiac Support Pump) to be equivalent to manual chest compressions.
From the Journal Sentinel (ResQPOD and ResQPump)
The brain’s ability to regain consciousness without a heartbeat may be an example of the improved cerebral blood flow obtained with two novel CPR devices that were the subject of a Medical College of Wisconsin study published online Tuesday in the Lancet.
The study involved standard CPR performed by emergency medical personnel and CPR using the two devices.
A total of 46 emergency medical service agencies serving 2 million to 3 million people in the U.S. took part in the study.
After one year, 6% of those who received standard CPR were still alive, compared with 9% among those treated with the devices.
Not only did the devices improve survival, but 9% of those treated with the devices were discharged from the hospital with favorable neurological function, compared with 6% of those receiving standard CPR. Favorable was defined as being able to live independently.